Rhythm Pharmaceuticals, Inc.

Direct answer

Rhythm Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker RYTM.

Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company with commercial products, dedicated to the discovery, development, and market launch of therapies addressing rare genetic conditions that cause obesity. Its leading pharmaceutical, IMCIVREE, functions as a powerful agonist of the melanocortin-4 receptor (MC4R). This medication is indicated for treating obesity stemming from deficiencies in...

Can you invest in Rhythm Pharmaceuticals, Inc.?

Yes. Rhythm Pharmaceuticals, Inc. trades publicly on NASDAQ as RYTM.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Rhythm Pharmaceuticals, Inc.

Detailed equity research is provided by MarketSnap.